AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06322472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Early Childhood Phonological Sensitivity Scale (PASECP)
Description: The Early Childhood Phonological Sensitivity Scale (PASECP), developed by Sarı and Aktan Acar (2013), measures the phonological awareness of children aged 60-72 months (Sari and Aktan Acar 2013).
Study NCT06322472 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: The Early Literacy Home Environment Scale (ELHES)
Description: The Early Literacy Home Environment Scale (ELHES) developed by Karaahmetoğlu and Turan is a reliable and valid questionnaire for assessing the early literacy home environment of families with children aged 0-6 years (Karaahmetoğlu and Turan 2020)
Study NCT06322472 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Demographic Questionaries
Description: The demographic survey was prepared by the researchers. The demographic survey includes questions about educational status and family's socio-economic status.
Study NCT06646198 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transjugular intrahepatic portosystemic shunt (TIPS)
Description: Perform transjugular intrahepatic portosystemic shunt under the guidance of DSA
Study NCT06646198 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donafenib
Description: Half-dose donafenib, 100mg BID P.O. unless any evidence of disease progression or unacceptable side effects.
Study NCT06198452 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vision Improvement
Description: Laser Vision Improvement for Patients with Age-Related Macular Degeneration
Study NCT05943496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acalabrutinib
Description: Given PO
Study NCT05943496 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05943496 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration
Description: Undergo bone marrow biopsy and/or aspiration
Study NCT05943496 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy and/or aspiration
Study NCT05943496 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT05943496 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO
Study NCT05943496 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Obinutuzumab
Description: Given IV
Study NCT05943496 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05943496 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tafasitamab
Description: Given IV
Study NCT06055517 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Pulsed low dose-rate radiotherapy (pLDRT)
Description: Radiation treatment will be carried out with high-energy photons (6MV) using intensity modulated radiation therapy (IMRT) or volumetric arc radiation therapy (VMAT). The daily dose is 2 Gy, divided into 10 subfractions of 0.2 Gy spaced by 3 minutes. The cumulative dose will be individualized for each patient and can range from a minimum of 40 Gy to a maximum of 60 Gy.
Study NCT05500495 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study NCT04924400 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CHIP Program
Description: GHP members randomized to the intervention arm will participate in the following activities:~* Attend 2 group meetings per week over 6 weeks, followed by one group meeting per week for 6 weeks (12 weeks total); each meeting will last about one hour. CHIP classes for weeks 1-4 and week 12 require in-person attendance, while week 5-11 classes can be attended either virtually or in-person.~* Receive a copy of The Optimal Diet, The Official CHIP Cookbook.~The following data will be collected at weeks 1,12 and 26:~* Biometrics: weight, BMI, waist circumference, systolic and diastolic blood pressure~* Biomarkers (blood tests): HbA1c, LDL-C~* Psychometrics: Wellbeing360 survey
Study NCT04924400 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: GHP members assigned to the control arm will receive the routine standard of care for GHP members. Members will receive a summary of diabetes-related benefits available to members with type 2 diabetes.~The following data will be collected at weeks 1,12 and 26:~* Biometrics: Weight, BMI, waist circumference, systolic and diastolic blood pressure~* Biomarkers (blood tests): HbA1c, LDL-C~* Psychometrics: Wellbeing360 survey
Study NCT05642897 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mind
Description: ACT, mindfulness, and compassion-based intervention
Study NCT05642897 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Support Group
Description: This intervention promotes the sharing of cancer-related experiences, active listening and a sense of community between participants.
Study NCT06575127 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFOXIRI Protocol
Description: as mentioned in Arm description
Study NCT06576518 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise
Description: An individualised incremental exercise programme was simultaneously supported by an adherence plan to assess and promote compliance.
Study NCT04898335 — intervention group
Intervention type: DEVICE
Intervention: Tendyne Mitral Valve System
Description: Tendyne Mitral Valve System for mitral valve disease in a commercial setting
Study NCT05437380 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: peritumoral microbubbles and contrast-enhanced ultrasonography
Description: Inject 1ml microbubbles around the tumors. Then detect lymph vessel and lymph nodes under contrast-enhanced ultrasonography.
Study NCT06048328 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Game Changers for Family Planning
Description: Game Changers for Family Planning (GC-FP) intervention. The intervention will consist of 6 group sessions. The sessions will focus on stigma reduction, disclosure decision making, knowledge, and building skills for advocacy. The 2-hour, weekly sessions will be facilitated by 2 trained peers who are MC users, and conducted in Luganda using a structured manual, and group format to facilitate: sharing of experiences to build support, modeling and motivation; group problem solving and role playing to build skills and self-efficacy; and homework between sessions to practice skills and generate experiences to be processed in the group.
Study NCT05864794 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI
Description: MRI scan of the brain
Study NCT05986071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M1774
Description: • Phase I part = administration of M1774 in combination with fulvestrant in ER+/HER2- ABC resistant to CDK4/6 inhibitor and aromatase inhibitor-based endocrine therapy in order to detemine the recommended phase II dose Phase II part = administration of M1774 at RP2D in combination with fulvestrant
Study NCT05986071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fulvestrant injection
Description: Phase I part = administration of M1774 in combination with fulvestrant in ER+/HER2- ABC resistant to CDK4/6 inhibitor and aromatase inhibitor-based endocrine therapy in order to detemine the recommended phase II dose Phase II part = administration of M1774 at RP2D in combination with fulvestrant
Study NCT05202691 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group 1 (Physical Therapy+Magnetic Field Therapy)
Description: A Physical Therapy Protocol (including manual therapy, stretching and exercise for low back pain) adding a Magnetic Field Therapy using the Zimmer EmfieldPro device (Zimmer MedizinSysteme, Germany)
Study NCT05202691 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group 2 (Physical Therapy)
Description: A Physical Therapy Protocol (including manual therapy, stretching and exercise for low back pain)
Study NCT06219382 — intervention group
Intervention type: DEVICE
Intervention: Neurorehabilitation ecosystem
Description: Over a period of six weeks, the participants will integrate the NEST system into their daily routines, running parallel to their regular neurorehabilitation treatment.
Study NCT06422611 — intervention group
Intervention type: DEVICE
Intervention: Impression methods
Description: Both digital and conventional impressions were taken from same patients
Study NCT04776174 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound using the telerobotic Melody system
Description: The children will first have a telerobotic ultrasound abdominal, pulmonary or cardiac followed by a classical ultrasound.
Study NCT05499494 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Beautifil Flow Plus X F00 injectable composite
Description: bioactive injectable composite
Study NCT05499494 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tetric N ceram resin composite
Description: Nano hybrid resin composite
Study NCT05950724 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etanercept Injection [Enbrel]
Description: 25 mg subcutaneous injection
Study NCT04981587 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Strength exercise
Description: Strength exercise protocol for upper and lower limbs, using weights and elastic bands
Study NCT04981587 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual treatment
Description: The usual treatment is based on activities to enhance brain functions: attention, memory, executive functions, language and orientation.
Study NCT06030999 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Study product A (Wonderlab wonder4shape)
Description: Participants in this arm need to consume one bottle (2g) of this product once a day for 10 weeks
Study NCT06030999 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Study product B (Wonderlab wonder4shape)
Description: Participants in this arm need to consume one bottle (2g) of this product once a day for 10 weeks
Study NCT06030999 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Study product C (placebo)
Description: Participants in this arm need to consume one bottle (2g) of this product once a day for 10 weeks
Study NCT06536842 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Postoperative Drain Placement
Description: These drains will be placed with the intention to decrease the incidence of postoperative hematoma
Study NCT06536842 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No Postoperative Drain Placement
Description: Participant will undergo lumbar spine fusion surgery and will not receive a postoperative drain
Study NCT06574659 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation breathing test guiding sequential invasive Ventilation and noninvasive ventilation weaing protocol
Description: Noninvasive ventilation breathing test guiding sequential invasive Ventilation and noninvasive ventilation weaing protocol
Study NCT06574659 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: The standard SBT guiding weaning group
Description: The standard SBT guiding weaning protocol
Study NCT04981587 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual treatment
Description: The usual treatment is based on activities to enhance brain functions: attention, memory, executive functions, language and orientation.
Study NCT05073016 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: neuromodulation
Description: neuromodulation: Neuromodulation is technology that acts directly upon nerves. It is the alteration-or modulation-of nerve activity by delivering electrical or magnetic stimulus/current.
Study NCT05073016 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: motor learning training
Description: motor learning training requires performing a sequential training called finger taping task
Study NCT06537518 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone injection
Description: Dexamethasone, a potent glucocorticoid, decreases the inflammatory response, tissue damage, and pain after surgical procedures; which can be injected locally or Intravenously.
Study NCT06537518 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine 0.375% Injectable Solution
Description: Isobaric bupivacaine (0.375%) is injected into the adductor canal deeply to the sartorius muscle around the saphenous nerve after ensuring negative aspiration space.
Study NCT06537518 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine 0.5% Injectable Solution
Description: 20 ml of Bupivacain 0.5% was mixed with dexamethasone 8 mg is injected into the adductor canal deeply to the sartorius muscle around the saphenous nerve after ensuring negative aspiration space.
Study NCT05064969 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blended intervention based in acceptance and commitment therapy
Description: Blended intervention includes completing 9 e-modules consist of written material, videos, and assignments (one e-module per week) that can be completed over 9 to 12 weeks AND 9 (to 12 ) coaching sessions (telephone call). Weekly coaching will be offered by a motivational coach based in Maastricht University.~After the post-intervention assessments, individuals will receive monthly calls from the motivational coach as booster sessions. Booster sessions will be received on monthly basis for a period of 6 months (one session per month) and until the last follow-up assessment. Communication with participants will take place online or via telephone.
Study NCT05938634 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage-matched interventions
Description: Precontemplation-based intervention Contemplation-based intervention Preparation-based intervention Action-based intervention Maintenance-based intervention
Study NCT05146869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DBPR108 tablets
Description: DBPR108 tablets, oral, once daily on Day 1 and Day 3-9 for a total of 8 doses.
Study NCT05394558 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AsiDNA
Description: Administration of AsiDNA followed by radiotherapy
Study NCT05394558 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AsiDNA
Description: Administration of AsiDNA followed by radiotherapy
Study NCT06109038 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional PT + ITB release with graston technique
Description: An emollient will be applied to the leg from the lateral joint line along the tibial condyle to just below the iliac crest. The instrument GT-4 will be used for treatment. The tool was used to assess the soft tissue in three locations on the lateral leg: anterior to the ITB, over the ITB, and posterior to the ITB. Brushing and strumming strokes were performed to the tissue utilising the instrument's convex surface. Treatment time with the instrument is 8 -10 mins .~Conventional PT including Hot Pack for 5mins. Quadriceps setting exercises, short arc terminal knee extension, straight leg raise, ROM exercises, hamstring curls in prone lying position, quadriceps strengthening in high sitting position, gastrocnemius muscle stretching (10reps × 5sec × 2sets). Maitland mobilization (Grade 1, 2 and 3 for 10 repetitions).
Study NCT06109038 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional PT
Description: Conventional PT including Hot Pack for 5mins. Quadriceps setting exercises, short arc terminal knee extension, straight leg raise, ROM exercises, hamstring curls in prone lying position, quadriceps strengthening in high sitting position, gastrocnemius muscle stretching (10reps × 5sec × 2sets). Maitland mobilization (Grade 1, 2 and 3 for 10 repetitions).
Study NCT06248034 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Smartphone application with tele-monitoring rehabilitation
Description: This Smartphone application includes an automated criterion-based progression based on participant's regular recorded self-measurement of knee range-of-motion and five-repetition-sit-to-stand. The rehabilitation program is designed to (i) increase knee range-of-motion, (ii) strengthen lower limb strength, (iii) improve postural balance, and (iv) improve physical function.
Study NCT06248034 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hospital-based rehabilitation program
Description: Participants will be provided with the usual preoperative, inpatient physiotherapy and a physiotherapy house visit within the first 2-weeks postoperation. Participants will receive exercises, patient education, manual therapy and other modalities that were prescribed and progressed at the project physiotherapist's discretion.
Study NCT06255288 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SNAK intervention
Description: The intervention consists of structured dialogue, patient information, and a protein supplement. The structured dialogue part of the intervention consists of an A3 poster with illustrations and keywords which will be hanging in the outpatient clinics. The poster will be utilized by nurses, patients, and their relatives to facilitate a dialogue regarding nutrition and wound healing. The patient information part of the intervention consists of a leaflet with easy-to-read information, which patients and their relatives can bring home after their visit to the outpatient clinic. The leaflet will consist of general information as well as food categories and recipes they can use to enhance their daily protein intake. For the protein supplement part of the intervention, the patients will have access to protein supplement beverages while they are in the outpatient clinic waiting room. Furthermore, they will receive prescriptions for protein drinks, that they can pick up at their local pharmacy.
Study NCT05043428 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The roles of peers and functional tasks in enhancing exercise training for adults with COPD: a pilot randomized controlled trial
Description: An 8 week two-arm pilot randomized control trial aimed to evaluate the effects of an online exercise and peer support intervention for people living with COPD.
Study NCT04796532 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home based HIIT
Description: Intervention will consist in a 16-week exercise program with HIIT with a frequency of 3 days/week. The Home-HIIT group participants will attend HIIT workout sessions supervised by a specialised instructor via a videoconference application. Every HIIT workout session will have a 10 minutes' warm-up, followed by an 8/12/16/20 minutes of HIIT (stages of physical adaptation every 4 weeks) training and 5 minutes' cool-down. Tabata method will be used with eight sets of 20 seconds of exercise bouts separated by 10 seconds rest, in 2 to 5 blocks. The intervention will have four stages of physical adaptation.~This group will have a follow-up period of 16 weeks.
Study NCT04796532 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional HIIT
Description: Intervention will consist in a 16-week exercise program with HIIT with a frequency of 3 days/week. The Traditional HIIT group participants will attend a group HIIT workout sessions supervised by a specialised instructor in a sport facility. Every HIIT workout session will have a 10 minutes' warm-up, followed by an 8/12/16/20 minutes of HIIT (stages of physical adaptation every 4 weeks) training and 5 minutes' cool-down. Tabata method will be used with eight sets of 20 seconds of exercise bouts separated by 10 seconds rest, in 2 to 5 blocks. The intervention will have four stages of physical adaptation.~This group will have a follow-up period of 16 weeks.
Study NCT04386681 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reentry Continuum for Brain Injury (RCBI)
Description: Pre-Release RCBI Treatment Procedures (BICS and ICAN). BICS: consists of 12 weekly two- hour sessions. Sessions focus on brain injury education, coping skills for the various symptoms of brain injury, depression management, stress management, and self- advocacy.~ICAN: delivered once a week for 6 weeks for 2 hours per session. ICAN primarily focuses on poor perspective-taking and inability to make social inferences about others' behaviors that are related to negative attributions, and employs role playing exercises and a novel perspective-positioning technique to elicit affective and cognitive empathy to alter negative attributions and reduce anger.~Post-Release RCBI Resource Facilitation. Working with their resource facilitator, alongside their corrections case manager, to work on brain injury specific reentry planning, resource, and needs identification.
Study NCT05997238 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: without triamcinolone
Description: The preparation contains only the basic formula. The base formula contains 150mg ropivacaine and 0.5mg epinephrine. Add normal saline and mix to 80ml.
Study NCT05043428 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The roles of peers and functional tasks in enhancing exercise training for adults with COPD: a pilot randomized controlled trial
Description: An 8 week two-arm pilot randomized control trial aimed to evaluate the effects of an online exercise and peer support intervention for people living with COPD.
Study NCT04684784 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intervention-Dry Needling
Description: Deep Dry Needling into the site of the latent TriggerPoint of the upper trapezius muscle. 1 session in upper trapezius muscle moving the needle up and down ten times.
Study NCT04684784 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Control-Dry Needling
Description: Sham Dry Needling into the site of the latent Trigger Point of the upper trapezius muscle with non-penetrating needles